| # | Title | Journal | Year | Citations |
|---|
| 1 | EAU Guidelines on Renal Cell Carcinoma: 2014 Update | European Urology | 2015 | 2,445 |
| 2 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 | European Urology | 2017 | 1,594 |
| 3 | EAU Guidelines on Interventional Treatment for Urolithiasis | European Urology | 2016 | 1,166 |
| 4 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 | European Urology | 2013 | 1,053 |
| 5 | European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update | European Urology | 2019 | 1,022 |
| 6 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update | European Urology | 2019 | 936 |
| 7 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update | European Urology | 2015 | 804 |
| 8 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update | European Urology | 2011 | 652 |
| 9 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update | European Urology | 2018 | 627 |
| 10 | EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder | European Urology | 2008 | 592 |
| 11 | EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis | European Urology | 2016 | 581 |
| 12 | European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update | European Urology | 2022 | 485 |
| 13 | European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update | European Urology | 2013 | 414 |
| 14 | Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy | European Urology | 2016 | 412 |
| 15 | European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update | European Urology | 2011 | 345 |
| 16 | Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? | European Urology | 2016 | 282 |
| 17 | Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel | European Urology | 2016 | 215 |
| 18 | Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review | European Urology | 2017 | 205 |
| 19 | Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature | European Urology | 2013 | 193 |
| 20 | Narrow Band Imaging Cystoscopy Improves the Detection of Non–muscle-invasive Bladder Cancer | Urology | 2010 | 139 |
| 21 | ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder | European Urology | 2013 | 137 |
| 22 | Pad weight testing in the evaluation of urinary incontinence | Neurourology and Urodynamics | 2014 | 133 |
| 23 | Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2010 | 131 |
| 24 | En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor | World Journal of Urology | 2015 | 124 |
| 25 | A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma | European Urology | 2017 | 123 |
| 26 | Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors | Cancer | 2001 | 120 |
| 27 | Associations of bisphenol A and polychlorinated biphenyls with spermatogenesis and steroidogenesis in two biological fluids from men attending an infertility clinic | Environment International | 2016 | 119 |
| 28 | Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016” | European Urology Focus | 2019 | 112 |
| 29 | Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer | Oncotarget | 2015 | 111 |
| 30 | Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer | European Urology | 2013 | 105 |
| 31 | Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review | European Urology Focus | 2019 | 103 |
| 32 | The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care | European Urology | 2021 | 103 |
| 33 | Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy | European Urology | 2013 | 101 |
| 34 | Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma | European Urology | 2021 | 98 |
| 35 | Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2009 | 96 |
| 36 | An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer | World Journal of Urology | 2018 | 95 |
| 37 | EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment | Neurourology and Urodynamics | 2020 | 88 |
| 38 | Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy | European Urology | 2016 | 85 |
| 39 | Determination of selected bisphenols, parabens and estrogens in human plasma using LC-MS/MS | Talanta | 2017 | 85 |
| 40 | “High-grade oncocytic renal tumor”: morphologic, immunohistochemical, and molecular genetic study of 14 cases | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2018 | 83 |
| 41 | Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus | European Urology | 2016 | 81 |
| 42 | Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma | European Urology | 2018 | 80 |
| 43 | 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19 | Nature Reviews Urology | 2021 | 80 |
| 44 | Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer | European Urology Focus | 2019 | 74 |
| 45 | Clinical and Cost Effectiveness of Hexaminolevulinate-guided Blue-light Cystoscopy: Evidence Review and Updated Expert Recommendations | European Urology | 2014 | 72 |
| 46 | Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel | European Urology Focus | 2020 | 72 |
| 47 | Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma | European Urology | 2017 | 69 |
| 48 | Division of Lymphatic Vessels at Varicocelectomy Leads to Testicular Oedema and Decline in Testicular Function According to the LH-RH Analogue Stimulation Test | European Urology | 2003 | 59 |
| 49 | Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer | BJU International | 2013 | 59 |
| 50 | Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer | Steroids | 2007 | 54 |
